Patents by Inventor Travis A. LEEAH

Travis A. LEEAH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ready to use liquid formulation
    Patent number: 11642308
    Abstract: Disclosed herein is a ready-to-use liquid, injectable formulation comprising lidocaine and epinephrine. Also disclosed herein is a process for preparing a ready-to-use liquid formulation comprising lidocaine and epinephrine, as well as methods for using the ready-to-use liquid formulation.
    Type: Grant
    Filed: January 13, 2021
    Date of Patent: May 9, 2023
    Assignee: QUVA PHARMA, INC.
    Inventors: Travis A. Leeah, Jianping Chen, Lijie Zhao
  • READY TO USE LIQUID FORMULATION
    Publication number: 20210251888
    Abstract: Disclosed herein is a ready-to-use liquid, injectable formulation comprising lidocaine and epinephrine. Also disclosed herein is a process for preparing a ready-to-use liquid formulation comprising lidocaine and epinephrine, as well as methods for using the ready-to-use liquid formulation.
    Type: Application
    Filed: January 13, 2021
    Publication date: August 19, 2021
    Applicant: QuVa Pharma, Inc.
    Inventors: Travis A. LEEAH, Jianping CHEN, Lijie ZHAO
  • Ready to use liquid formulation
    Patent number: 10952962
    Abstract: Disclosed herein is a ready-to-use liquid formulation comprising lidocaine hydrochloride and epinephrine hydrochloride. Also disclosed herein is a process for preparing a ready-to-use liquid formulation comprising lidocaine hydrochloride and epinephrine hydrochloride, as well as methods for using the ready-to-use liquid formulation.
    Type: Grant
    Filed: April 11, 2019
    Date of Patent: March 23, 2021
    Assignee: QuVa Pharma, Inc.
    Inventors: Travis A. Leeah, Jianping Chen
  • Ready to use liquid RECK formulation
    Patent number: 10952963
    Abstract: Disclosed herein is a ready-to-use liquid formulation comprising ropivacaine, epinephrine, clonidine, and ketorolac (collectively referred to as RECK). Also disclosed herein is a process for preparing the RECK-containing liquid formulation, as well as methods for using the same.
    Type: Grant
    Filed: April 11, 2019
    Date of Patent: March 23, 2021
    Assignee: QuVa Pharma, Inc.
    Inventors: Travis A. Leeah, Jianping Chen
  • READY TO USE LIQUID RECK FORMULATION
    Publication number: 20190314278
    Abstract: Disclosed herein is a ready-to-use liquid formulation comprising ropivacaine, epinephrine, clonidine, and ketorolac (collectively referred to as RECK). Also disclosed herein is a process for preparing the RECK-containing liquid formulation, as well as methods for using the same.
    Type: Application
    Filed: April 11, 2019
    Publication date: October 17, 2019
    Applicant: QuVa Pharma, Inc.
    Inventors: Travis A. LEEAH, Jianping CHEN